{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T18:54:34Z","timestamp":1777920874326,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.bioorg.2022.105809","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T02:53:25Z","timestamp":1649904805000},"page":"105809","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Novel 2-arylthiazolidin-4-one-thiazole hybrids with potent activity against Mycobacterium tuberculosis"],"prefix":"10.1016","volume":"124","author":[{"given":"Dina I.A.","family":"Othman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelrahman","family":"Hamdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwa M.","family":"Abdel-Aziz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherin M.","family":"Elfeky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bioorg.2022.105809_b0005","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.rppnen.2017.10.009","article-title":"New drugs and perspectives for new anti-tuberculosis regimens","volume":"24","author":"Tiberi","year":"2018","journal-title":"Pulmonology"},{"issue":"4","key":"10.1016\/j.bioorg.2022.105809_b0010","doi-asserted-by":"crossref","first-page":"323","DOI":"10.5603\/ARM.34896","article-title":"Guidelines of Polish Respiratory Society concerning diagnosis, treatment and prevention of tuberculosis in adults and in children","volume":"81","author":"Augustynowicz-Kope\u0107","year":"2013","journal-title":"Advances in Respiratory Medicine"},{"issue":"1","key":"10.1016\/j.bioorg.2022.105809_b0015","first-page":"23","article-title":"Secondary bacterial infection in active pulmonary tuberculosis","volume":"29","author":"Shaddock","year":"2014","journal-title":"Southern African Journal of Infectious Diseases"},{"key":"10.1016\/j.bioorg.2022.105809_b0020","first-page":"14289","article-title":"Gram positive and gram negative bacteria from sputum of clinically tuberculosis suspected patients","volume":"7","author":"Hasan","year":"2015","journal-title":"Intenational Journal of Current Research"},{"issue":"9","key":"10.1016\/j.bioorg.2022.105809_b0025","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.3201\/eid1309.070443","article-title":"Extensively drug-resistant Mycobacterium tuberculosis, India","volume":"13","author":"Mondal","year":"2007","journal-title":"Emerg. Infect. Dis."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105809_b0030","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2174\/138920013804545151","article-title":"Metabolism of the antituberculosis drug ethionamide","volume":"14","author":"Vale","year":"2013","journal-title":"Curr. Drug Metab."},{"issue":"24","key":"10.1016\/j.bioorg.2022.105809_b0035","doi-asserted-by":"crossref","first-page":"13881","DOI":"10.1073\/pnas.2235848100","article-title":"The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: adduct affinity and drug resistance","volume":"100","author":"Rawat","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105809_b0040","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1128\/CMR.18.1.81-101.2005","article-title":"Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis","volume":"18","author":"Takayama","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"issue":"2","key":"10.1016\/j.bioorg.2022.105809_b0045","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.pharep.2017.09.001","article-title":"Novel compounds targeting InhA for TB therapy","volume":"70","author":"AlMatar","year":"2018","journal-title":"Pharmacol. Rep."},{"issue":"10","key":"10.1016\/j.bioorg.2022.105809_b0050","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1124\/dmd.104.000273","article-title":"Triclosan as a substrate and inhibitor of 3\u2032-phosphoadenosine 5\u2032-phosphosulfate-sulfotransferase and UDP-glucuronosyl transferase in human liver fractions","volume":"32","author":"Wang","year":"2004","journal-title":"Drug Metab. Dispos."},{"issue":"21","key":"10.1016\/j.bioorg.2022.105809_b0055","doi-asserted-by":"crossref","first-page":"6308","DOI":"10.1021\/jm060715y","article-title":"Pyrrolidine carboxamides as a novel class of inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis","volume":"49","author":"He","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105809_b0060","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejmech.2015.10.008","article-title":"Structure activity relationships of 4-hydroxy-2-pyridones: A novel class of antituberculosis agents","volume":"106","author":"Ng","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.105809_b0065","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ejmech.2016.02.008","article-title":"New direct inhibitors of InhA with antimycobacterial activity based on a tetrahydropyran scaffold","volume":"112","author":"Pajk","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105809_b0070","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/jccs.200700002","article-title":"Synthesis and Anti Tuberculostatic Activity of Novel 1, 3, 4-Oxadiazole Derivatives","volume":"54","author":"Yar","year":"2007","journal-title":"J. Chin. Chem. Soc."},{"key":"10.1016\/j.bioorg.2022.105809_b0075","first-page":"2565","article-title":"Design, synthesis and in-silico study of novel series of 2-phenyl-3-(5-sulfanyl-1, 3, 4-thiadiazol-2-Yl)-1, 3-thiazolidin-4-one derivatives with potential anti-tubercular activity","volume":"10","author":"Dadlani","year":"2019","journal-title":"International Journal of Pharmaceutical Sciences and Research."},{"key":"10.1016\/j.bioorg.2022.105809_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmcr.2021.100002","article-title":"Thiazole, triazole, thio-and semicarbazone derivatives-Promising moieties for drug development for the treatment of tuberculosis","volume":"1","author":"Scarim","year":"2021","journal-title":"European Journal of Medicinal Chemistry Reports"},{"issue":"6","key":"10.1016\/j.bioorg.2022.105809_b0085","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1021\/cr800278z","article-title":"Mitsunobu and related reactions: advances and applications","volume":"109","author":"Swamy","year":"2009","journal-title":"Chem. Rev."},{"issue":"11","key":"10.1016\/j.bioorg.2022.105809_b0090","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1128\/AAC.00699-11","article-title":"Clofazimine analogs with efficacy against experimental tuberculosis and reduced potential for accumulation","volume":"55","author":"Lu","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105809_b0095","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1080\/14756366.2020.1868450","article-title":"Development of novel isatin\u2013nicotinohydrazide hybrids with potent activity against susceptible\/resistant Mycobacterium tuberculosis and bronchitis causing\u2013bacteria","volume":"36","author":"Elsayed","year":"2021","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2022.105809_b0100","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1128\/AAC.48.5.1879-1881.2004","article-title":"Rapid colorimetric assay for antimicrobial susceptibility testing of Pseudomonas aeruginosa","volume":"48","author":"Tunney","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2022.105809_b0105","unstructured":"Sivaraman, S., Structure-activity studies of the inhibition of FabI, the enoyl ACP reductase from Escherichia coli by triclosan. 2002: State University of New York at Stony Brook."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105809_b0110","doi-asserted-by":"crossref","first-page":"1900211","DOI":"10.1002\/ardp.201900211","article-title":"Synthesis, biological screening, and molecular docking of quinazolinone and quinazolinethione as phosphodiesterase 7 inhibitors","volume":"353","author":"Elfeky","year":"2020","journal-title":"Arch. Pharm."},{"issue":"2","key":"10.1016\/j.bioorg.2022.105809_b0115","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3390\/ijms19020630","article-title":"Molecular modeling study for the design of novel peroxisome proliferator-activated receptor gamma agonists using 3D-QSAR and molecular docking","volume":"19","author":"Jian","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105809_b0120","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/jhet.5570440106","article-title":"A novel synthesis of some 2-imino-4-thiazolidinone derivatives","volume":"44","author":"Moghaddam","year":"2007","journal-title":"J. Heterocycl. Chem."},{"issue":"23","key":"10.1016\/j.bioorg.2022.105809_b0125","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1016\/j.tetlet.2004.04.055","article-title":"Reeve's synthesis of 2-imino-4-thiazolidinone from alkyl (aryl) trichloromethylcarbinol revisited, a three-component process from aldehyde, chloroform and thiourea","volume":"45","author":"Blanchet","year":"2004","journal-title":"Tetrahedron Lett."},{"issue":"11","key":"10.1016\/j.bioorg.2022.105809_b0130","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3184\/030823409X12559727242438","article-title":"One pot synthesis of 1, 3, 4-thiadiazole thiazolidinone derivatives","volume":"2009","author":"Wang","year":"2009","journal-title":"J. Chem. Res."},{"issue":"38","key":"10.1016\/j.bioorg.2022.105809_b0135","doi-asserted-by":"crossref","first-page":"7619","DOI":"10.1016\/S0040-4020(02)00866-9","article-title":"Carbodiimide mediated synthesis of 4-thiazolidinones by one-pot three-component condensation","volume":"58","author":"Srivastava","year":"2002","journal-title":"Tetrahedron"},{"issue":"1","key":"10.1016\/j.bioorg.2022.105809_b0140","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.farmac.2003.09.001","article-title":"Synthesis of new 2, 3-diaryl-1, 3-thiazolidin-4-ones as anti-HIV agents","volume":"59","author":"Rao","year":"2004","journal-title":"Il Farmaco"},{"issue":"2","key":"10.1016\/j.bioorg.2022.105809_b0145","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1021\/cc700164u","article-title":"Microwave-assisted fluorous synthesis of 2-aryl-substituted 4-thiazolidinone and 4-thiazinanone libraries","volume":"10","author":"Zhou","year":"2008","journal-title":"J. Comb. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105809_b0150","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/157018011793663958","article-title":"Synthesis and evaluation of antimicrobial activity of thiazolidinone derivatives","volume":"8","author":"Veerasamy","year":"2011","journal-title":"Lett. Drug Des. Discovery"},{"issue":"4","key":"10.1016\/j.bioorg.2022.105809_b0155","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/jhet.5570450409","article-title":"Synthesis and biological evaluation of novel methylene-bisthiazolidinone derivatives as potential nematicidal agents","volume":"45","author":"Srinivas","year":"2008","journal-title":"J. Heterocycl. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2022.105809_b0160","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1002\/jhet.1047","article-title":"One-Pot Three-Component Mild Synthesis of 2-Aryl-3-(9-alkylcarbazol-3-yl) thiazolidin-4-ones","volume":"49","author":"Li","year":"2012","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.bioorg.2022.105809_b0165","doi-asserted-by":"crossref","unstructured":"H Brooks, W., W. C Guida, and K. G Daniel, The significance of chirality in drug design and development. Current Topics In Medicinal Chemistry, 2011. 11(7): p. 760-770.","DOI":"10.2174\/156802611795165098"},{"issue":"9","key":"10.1016\/j.bioorg.2022.105809_b0170","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1021\/acs.jmedchem.0c00007","article-title":"Fragment-based design of Mycobacterium tuberculosis InhA inhibitors","volume":"63","author":"Sabbah","year":"2020","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105809_b0175","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1021\/acs.jcim.9b00918","article-title":"Discovery of new and potent inha inhibitors as antituberculosis agents: structure-based virtual screening validated by biological assays and x-ray crystallography","volume":"60","author":"Kamsri","year":"2020","journal-title":"J. Chem. Inf. Model."},{"issue":"2","key":"10.1016\/j.bioorg.2022.105809_b0180","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/cmdc.200800261","article-title":"Triclosan derivatives: towards potent inhibitors of drug-sensitive and drug-resistant Mycobacterium tuberculosis","volume":"4","author":"Freundlich","year":"2009","journal-title":"ChemMedChem"},{"issue":"4","key":"10.1016\/j.bioorg.2022.105809_b0185","doi-asserted-by":"crossref","DOI":"10.4314\/tjpr.v11i4.12","article-title":"Synthesis and antitubercular activity of some novel thiazolidinone derivatives","volume":"11","author":"Malipeddi","year":"2012","journal-title":"Trop. J. Pharm. Res."},{"issue":"4","key":"10.1016\/j.bioorg.2022.105809_b0190","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1093-3263(01)00123-1","article-title":"Beware of q2!","volume":"20","author":"Golbraikh","year":"2002","journal-title":"J. Mol. Graph. Model."},{"issue":"1-3","key":"10.1016\/j.bioorg.2022.105809_b0195","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105809_b0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.bioorg.2022.105809_b0205","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1021\/ci500467k","article-title":"iLOGP: a simple, robust, and efficient description of n-octanol\/water partition coefficient for drug design using the GB\/SA approach","volume":"54","author":"Daina","year":"2014","journal-title":"J. Chem. Inf. Model."},{"issue":"20","key":"10.1016\/j.bioorg.2022.105809_b0210","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1021\/jm000942e","article-title":"Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties","volume":"43","author":"Ertl","year":"2000","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2022.105809_b0215","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1021\/ci300447c","article-title":"In silico prediction of aqueous solubility using simple QSPR models: the importance of phenol and phenol-like moieties","volume":"52","author":"Ali","year":"2012","journal-title":"J. Chem. Inf. Model."},{"issue":"11","key":"10.1016\/j.bioorg.2022.105809_b0220","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/cmdc.201600182","article-title":"A boiled-egg to predict gastrointestinal absorption and brain penetration of small molecules","volume":"11","author":"Daina","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2022.105809_b0225","series-title":"EuroQSAR 2002 Designing Drugs and Crop Protectants: processes, problems and solutions","first-page":"418","article-title":"The PreADME Approach: Web-based program for rapid prediction of physico-chemical, drug absorption and drug-like properties","author":"Lee","year":"2003"},{"key":"10.1016\/j.bioorg.2022.105809_b0230","first-page":"5","article-title":"The PreADME: pc-based program for batch prediction of adme properties","volume":"9","author":"Lee","year":"2004","journal-title":"EuroQSAR"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822002140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822002140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:31:14Z","timestamp":1758616274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206822002140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":46,"alternative-id":["S0045206822002140"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.105809","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel 2-arylthiazolidin-4-one-thiazole hybrids with potent activity against Mycobacterium tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.105809","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105809"}}